We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

Nasdaq:ACAD

Acadia Pharmaceuticals Inc. (ACAD)

Nasdaq • ACAD • US0042251084

21.50Last close

Market Closed

Trading Signals

ORTEX Data Highlights

As of Nov 3, 2026, ORTEX estimates 6.9% of free float is sold short, 5.8 days to cover, cost to borrow 0.38%.

Market Cap

3.7b USD | # 3020 in US

Volume

1.91m shares | 46.87m USD

Shares Outstanding

172.31m

Free Float Shares

74.49% | 128.35m

DB:DR6|

LSE:0A4W

News

ACAD key data

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) has a market capitalization of $3.7B. Last close $21.50 (as of 2026-11-05); 52-week range $18.39 to $30.96. ORTEX data as of 2026-11-03: short interest is 6.94% of free float, 5.8 days to cover and the average cost to borrow is 0.38%.

ACAD news on ORTEX News
ORTEX News
ORTEX public data
ORTEX Charts
ORTEX API

© 2026 ORTEX Technologies Ltd.